Loading provider…
Loading provider…
Hematology & Oncology Physician in Burlington, MA
NPI: 1205867108Primary Practice Location
LAHEY HOSPITAL & MEDICAL CENTER, BURLINGTON
41 Burlington Mall Rd, Burlington, MA
Primary Employer
Lahey Clinic
bilh.org
HQ Phone
Get MD Keith's Phone Numberphone_androidMobile
Get MD Keith's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 169 | 275 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 97 | 316 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 36 | 36 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 32 | 32 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 18 | 32 |
A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor.
Authors: Lawrence Blaszkowsky, Raymond Wadlow
Publication Date: 2013-01-23
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer.
Authors: Rakesh Jain, Weijing Sun, Francis Nugent, Mary Mulcahy, Jayne Gurtler
Publication Date: 2013-10-04
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, DRUG: Cabozantinib S-malate
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Cetuximab, BIOLOGICAL: Trastuzumab, DRUG: Irinotecan Hydrochloride, BIOLOGICAL: Pertuzumab, DEVICE: HER-2 testing
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Gemcitabine Hydrochloride, DRUG: Fluorouracil, DRUG: Oxaliplatin, DRUG: Irinotecan Hydrochloride, DRUG: Paclitaxel Albumin-Stabilized Nanoparticle Formulation, PROCEDURE: Pancreatectomy